Novo Nordisk A/S ADR | Cash Flow
Fiscal year is January-December. All values DKK Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
25,184
26,481
34,860
37,925
38,130
38,628
Depreciation, Depletion & Amortization
2,655
2,796
2,959
3,067
2,870
3,809
Other Funds
1,632
4,563
2,625
11,056
1,826
6,528
Funds from Operations
26,207
33,840
40,444
52,048
43,239
48,005
Changes in Working Capital
265
2,148
2,157
3,708
2,045
3,370
Net Operating Cash Flow
25,942
31,692
38,287
48,340
41,194
44,635
Capital Expenditures
3,644
3,990
6,406
8,267
8,648
Sale of Fixed Assets & Businesses
31
4
2,318
7
9
Purchase/Sale of Investments
840
2,267
2,010
1,533
2,009
Net Investing Cash Flow
2,773
2,064
6,098
6,816
6,597
Cash Dividends Paid - Total
9,715
11,866
12,905
23,830
18,844
Net Financing Cash Flow
23,639
26,533
30,101
38,887
35,689
Net Change in Cash
540
3,163
2,174
2,611
1,303
Free Cash Flow
22,704
27,702
33,063
41,272
33,568
Deferred Taxes & Investment Tax Credit
-
-
-
-
413
960
Other Sources
-
-
-
23
73
Change in Capital Stock
13,924
14,667
17,196
15,057
16,845
Exchange Rate Effect
70
68
86
26
211
Other Uses
-
345
-
112
40
About Novo Nordisk A/S
View Profile
